IGM Biosciences, Inc. Accrued Liabilities, Current
IGM Biosciences, Inc. had Accrued Liabilities, Current of $3.66 million as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2025-07-31
- 2025-06-30: Accrued Liabilities, Current $3.66M.
- 2025-03-31: Accrued Liabilities, Current $17.13M.
- 2024-12-31: Accrued Liabilities, Current $26.88M.
- 2024-09-30: Accrued Liabilities, Current $31.07M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2025-06-30 | $3.66M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $17.13M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $26.88M 10-Q · filed 2025-07-31 |
| 2024-09-30 | $31.07M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $26.46M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $23.65M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $31.54M 10-K · filed 2025-03-06 |
| 2023-09-30 | $27.93M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $27.74M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $29.64M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $33.62M 10-K · filed 2024-03-07 |
| 2022-09-30 | $32.65M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $24.57M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $19.30M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $18.88M 10-K · filed 2023-03-30 |
| 2021-09-30 | $13.93M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $10.71M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $5.83M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $6.65M 10-K · filed 2022-03-29 |
| 2020-09-30 | $7.47M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $4.33M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $3.03M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $3.31M 10-K · filed 2021-03-30 |
| 2019-09-30 | $2.08M 10-Q · filed 2019-11-07 |
| 2018-12-31 | $3.58M 10-K · filed 2020-03-26 |